Logistics group Imperial Holdings will buy a 70% interest in Kenyan pharmaceutical group Surgipharm for R470m in cash, subject to regulatory approvals. Surgipharm, headquartered in Nairobi and with offices in Mombasa, is a distributor of pharmaceutical, medical and surgical supplies in the country, with an annual turnover of about R940m. It has more than 330 employees, about 4,700m² of warehousing and its own transport fleet catering to the ministry of health, nongovernment organisations, hospitals, clinics, doctors, pharmacies and wholesalers. Key management will retain their roles. Imperial says the deal is in line with its African growth strategy to be a partner of multinational companies in the consumer goods and pharmaceutical sectors in southern, eastern and western Africa. “Our entry into pharmaceutical distribution in Kenya is also opportune at a time where there is GDP growth, rising income levels and a rising middle class in the region,” Mark Lamberti, group CEO of Imperia...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.